Paydirt
IMVT
Ticker

Immunovant, Inc.

IMVT · Healthcare · Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases

Immunovant, Inc. (IMVT), in the Healthcare sector, has 22 disclosed filings on Paydirt over the trailing twelve months from 9 corporate insiders: 1 purchase and 21 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Oct 28 and filed Oct 30. The most active filer was Tiago Girao with 4 filings. Data as of Nov 8 2026.

Add to watchlist
Filings, ttm
22
1 buy · 21 sells
Traders, ttm
9
9 insiders
Volume, ttmiDollar value disclosed in the window
$364.5M
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Oct 28
Filed Oct 30
ADViAverage daily dollar volume
$75.6M
market data
Share price · 12M
$28.39 (+21.5%)
$44.96$33.49$22.02Nov 10 2025May 11Nov 5

Adjusted for splits and dividends.

Volume by month
$350.0M$175.0M$0Dec 2024Jun 2025Dec 2025Jun 2026Dec 2024 · sells $376KJan 2025 · buys $336.9MJan 2025 · sells $322KFeb 2025 · sells $322KMar 2025 · sells $129KApr 2025 · sells $489KNov 2025 · sells $241KDec 2025 · buys $350.0MDec 2025 · sells $979KApr 2026 · sells $1.6MMay 2026 · sells $7.6MJun 2026 · sells $3.3MJul 2026 · sells $493KAug 2026 · sells $135KOct 2026 · sells $308K
Buys $686.9M Sells $16.3M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
PS Peter Salzmann Chief Executive Officer 6 filings · 0 buys, 6 sales TG Tiago Girao Chief Financial Officer 4 filings · 0 buys, 4 sales MG Melanie Gloria Chief Operating Officer 4 filings · 0 buys, 4 sales AF Andrew J. Fromkin Director 3 filings · 0 buys, 3 sales JS Jay S Stout Chief Technology Officer 3 filings · 0 buys, 3 sales CT Christopher Van Tuyl Chief Legal Officer 3 filings · 0 buys, 3 sales EV Eric Venker President & Immunovant CEO 3 filings · 0 buys, 3 sales DH Douglas J. Hughes Director 2 filings · 0 buys, 2 sales
All 11 filers AP Atul Pande Director 2 filings · 0 buys, 2 sales RL Roivant Sciences Ltd. Director 2 filings · 2 buys, 0 sales EB Eva Renee Barnett Chief Financial Officer 1 filing · 0 buys, 1 sale
Recent filings
Tiago GiraoSALE Chief Financial Officer $188K
6,606 sh × $28.50
Exec Oct 28
Filed Oct 30 · 4:37 PM ET Eric VenkerSALE Chief Executive Officer $120K
3,506 sh × $34.11
Exec Oct 2
Filed Oct 5 · 7:42 PM ET Melanie GloriaSALE Chief Operating Officer $135K
3,056 sh × $44.16
Exec Aug 20
Filed Aug 21 · 4:03 PM ET Tiago GiraoSALE Chief Financial Officer $263K
6,798 sh × $38.69
Exec Jul 23
Filed Jul 24 · 5:57 PM ET Jay S StoutSALE Chief Technology Officer $111K
2,857 sh × $38.69
Exec Jul 23
Filed Jul 24 · 5:57 PM ET Eric VenkerSALE Chief Executive Officer $119K
3,092 sh × $38.48
Exec Jul 2
Filed Jul 6 · 5:01 PM ET Tiago GiraoSALE Chief Financial Officer $385K
10,000 sh × $38.46
Exec Jun 26
Filed Jun 26 · 5:30 PM ET Christopher Van TuylSALE Chief Legal Officer $683K
17,824 sh across 2 lots
Exec Jun 26
Filed Jun 26 · 5:30 PM ET Jay S StoutSALE Chief Technology Officer $1.5M
40,000 sh across 2 lots
Exec Jun 26
Filed Jun 26 · 5:30 PM ET Melanie GloriaSALE Chief Operating Officer $679K
17,714 sh across 2 lots
Exec Jun 26
Filed Jun 26 · 5:30 PM ET Andrew J. FromkinSALE Director $7.4M
221,951 sh across 2 lots
Exec May 28
Filed May 29 · 5:30 PM ET Atul PandeSALE Director $192K
6,000 sh × $32.00
Exec May 20
Filed May 20 · 5:30 PM ET Tiago GiraoSALE Chief Financial Officer $763K
25,760 sh × $29.62
Exec Apr 23
Filed Apr 24 · 5:30 PM ET Jay S StoutSALE Chief Technology Officer $214K
8,614 sh × $24.83
Exec Apr 8
Filed Apr 10 · 5:30 PM ET Melanie GloriaSALE Chief Operating Officer $217K
8,722 sh × $24.83
Exec Apr 8
Filed Apr 10 · 5:30 PM ET Christopher Van TuylSALE Chief Legal Officer $128K
5,165 sh × $24.83
Exec Apr 8
Filed Apr 10 · 5:30 PM ET Eric VenkerSALE Chief Executive Officer $308K
12,820 sh × $24.04
Exec Apr 2
Filed Apr 3 · 5:30 PM ET Christopher Van TuylSALE Chief Legal Officer $228K
8,529 sh × $26.78
Exec Dec 18 2025
Filed Dec 19 2025 · 5:30 PM ET Roivant Sciences Ltd.PURCHASE Director $350.0M
16,666,666 sh × $21.00
Exec Dec 12 2025
Filed Dec 12 2025 · 5:17 PM ET Douglas J. HughesSALE Director $303K
13,091 sh × $23.14
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET Andrew J. FromkinSALE Director $448K
19,351 sh × $23.14
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET Melanie GloriaSALE Chief Operating Officer $241K
10,251 sh × $23.54
Exec Nov 20 2025
Filed Nov 21 2025 · 5:30 PM ET Peter SalzmannSALE Chief Executive Officer $124K
8,321 sh × $14.89
Exec Apr 16 2025
Filed Apr 17 2025 · 5:30 PM ET Peter SalzmannSALE Chief Executive Officer $365K
28,094 sh × $12.99
Exec Apr 9 2025
Filed Apr 11 2025 · 5:30 PM ET Andrew J. FromkinSALE Director $129K
6,616 sh × $19.52
Exec Mar 7 2025
Filed Mar 11 2025 · 5:30 PM ET